Back

Medscape, LLC

  • Alzheimer Disease

How Recent Updates Are Informing the Use of Anti-Amyloid Therapies in Early Alzheimer’s Disease

The goal of this activity is for learners to be better able to summarize recent data on the use of anti-amyloid therapies (AATs) for early stages of AD; select and monitor patients receiving an AAT for the management of early stages of AD.

Credit & MOC Details

Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.

Credit types

AMA PRA Category 1 Credit™Up to 0.5 credits

MOC types

No MOC

FDA REMS

No

Qualifies for MIPS

No

Target Specialties

Pricing

Free

Reported to ACCME by the provider

  • Enduring / On-demand
  • Credit · Up to 0.5 credits
  • Commercial Support
  • Released
    Aug 13, 2026
  • Last day to claim credit
    Aug 14, 2027 10 months left